Buss, Lewis Fletcher 
; Prete Junior, Carlos Augusto ; Whittaker, Charles ; Salomon, Tassila ; Oikawa, Márcio Katsumi ; Pereira, Rafael H. M. ; Moura, Isabel C. G.; Delerino, Lucas; Franca, Rafael Freitas de Oliveira ; Miyajima, Fabio; Mendrone Júnior, Alfredo ; Almeida Neto, César de ; Salles, Nanci A. ; Ferreira, Suzete Cleuza ; Fladzinski, Karine A.; Souza, Luana Mendes de; Schier, Luciane K.; Inoue, Patricia M.; Kabregas, Lilyane A. Xabregas; Crispim, Myuki A. E. ; Fraiji, Nelson A ; Calos, Luciana M. B.; Pessoa, Veridiana Pessoa; Ribeiro, Maisa A.; Souza, Rosenvaldo E. de; Cavalcante, Anna F.; Valença, Maria I. B.; Silva, Maria V. da; Lopes, Esther; Filho, Luiz A.; Mateos, Sheila de Oliveira Garcia; Nunes, Gabrielle T.; Schlesinger, David; Silva, Sônia Mara Nunes da; Silva-Junior, Alexander L. ,; Castro, Marcia C. ; Nascimento, Vítor Heloiz ; Dye, Christopher ; Busch, Michael P; Faria, Nuno Rodrigues ; Sabino, Ester Cerdeira
Source: Vaccines. Unidades: EP, IMT
Subjects: COVID-19, IMUNIDADE, VACINAS
ABNT
BUSS, Lewis Fletcher et al. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors. Vaccines, v. 10, n. 9, p. 1437-1447, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091437. Acesso em: 18 nov. 2024.APA
Buss, L. F., Prete Junior, C. A., Whittaker, C., Salomon, T., Oikawa, M. K., Pereira, R. H. M., et al. (2022). Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors. Vaccines, 10( 9), 1437-1447. doi:10.3390/vaccines10091437NLM
Buss LF, Prete Junior CA, Whittaker C, Salomon T, Oikawa MK, Pereira RHM, Moura ICG, Delerino L, Franca RF de O, Miyajima F, Mendrone Júnior A, Almeida Neto C de, Salles NA, Ferreira SC, Fladzinski KA, Souza LM de, Schier LK, Inoue PM, Kabregas LAX, Crispim MAE, Fraiji NA, Calos LMB, Pessoa VP, Ribeiro MA, Souza RE de, Cavalcante AF, Valença MIB, Silva MV da, Lopes E, Filho LA, Mateos S de OG, Nunes GT, Schlesinger D, Silva SMN da, Silva-Junior AL, Castro MC, Nascimento VH, Dye C, Busch MP, Faria NR, Sabino EC. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors [Internet]. Vaccines. 2022 ;10( 9): 1437-1447.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/vaccines10091437Vancouver
Buss LF, Prete Junior CA, Whittaker C, Salomon T, Oikawa MK, Pereira RHM, Moura ICG, Delerino L, Franca RF de O, Miyajima F, Mendrone Júnior A, Almeida Neto C de, Salles NA, Ferreira SC, Fladzinski KA, Souza LM de, Schier LK, Inoue PM, Kabregas LAX, Crispim MAE, Fraiji NA, Calos LMB, Pessoa VP, Ribeiro MA, Souza RE de, Cavalcante AF, Valença MIB, Silva MV da, Lopes E, Filho LA, Mateos S de OG, Nunes GT, Schlesinger D, Silva SMN da, Silva-Junior AL, Castro MC, Nascimento VH, Dye C, Busch MP, Faria NR, Sabino EC. Predicting SARS-CoV-2 variant spread in a completely seropositive population using semi-quantitative antibody measurements in blood donors [Internet]. Vaccines. 2022 ;10( 9): 1437-1447.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/vaccines10091437
